New Era For Schizophrenia Therapy Beckons As Karuna Soars On Promising Phase III Data

Mechanism Exceeds Efficacy Expectations

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.